Real-World Data as External Control in Assessing the Efficacy of Allogeneic Adipose-Derived Stem Cells Therapy for Advanced Chronic Kidney Disease.

Clin Transl Sci · 2025 · PMC12657255 · PMID 41299839

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although results at the other thresholds did not reach statistical significance, the hazard ratios consistently favored the ADSC therapy group, indicating a trend toward reduced risk of renal function decline.

also in 111,027 other papers

a positive trendno p-value reported

Figure 5 Part B shows the percentage change in eGFR from baseline, where the ADSC therapy low‐dose group consistently maintained a positive trend, indicating stable renal function, while the RWD EC group showed a progressive decline.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.